NCT04082364 2025-06-08
MAHOGANY
MacroGenics
Phase 2/3 Completed
Clinical Trials
21 trialsNCT02807181 2025-05-09
SIRCCA
Sirtex Medical
Phase 2/3 Terminated
NCT04068103 2025-05-07
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Phase 2/3 Active not recruiting
NCT04499924 2025-01-22
MOUNTAINEER-02
Seagen Inc.
Phase 2/3 Completed
NCT03512756 2024-11-06
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Tyme, Inc
Phase 2/3 Terminated
NCT01515787 2024-02-02
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
Phase 2/3 Unknown
NCT03414983 2023-11-18
CheckMate 9X8
Bristol-Myers Squibb
Phase 2/3 Completed
NCT04066491 2023-11-14
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
EMD Serono
Phase 2/3 Terminated
NCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT02614703 2021-08-27
"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
DHR Health Institute for Research and Development
Phase 2/3 Terminated
NCT03093870 2021-08-03
TreeTopp
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT02195232 2021-03-03
CATIQ
Dana-Farber Cancer Institute
Phase 2/3 Completed
NCT01446874 2018-11-08
POPP
Washington University School of Medicine
Phase 2/3 Terminated
NCT02163187 2018-02-05
Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
Memorial Sloan Kettering Cancer Center
Phase 2/3 Terminated
NCT01683864 2018-01-30
HIPECStomach
University Hospital Tuebingen
Phase 2/3 Terminated
NCT01641939 2017-05-12
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
Hoffmann-La Roche
Phase 2/3 Terminated
NCT00384176 2017-04-14
HORIZON III
AstraZeneca
Phase 2/3 Completed
NCT00153816 2017-03-15
Vitamin D/Calcium Polyp Prevention Study
Dartmouth-Hitchcock Medical Center
Phase 2/3 Completed
NCT01103479 2015-05-06
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Northwestern University
Phase 2/3 Completed
NCT00510692 2014-08-22
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00328770 2013-06-24
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
University of Alberta
Phase 2/3 Completed